Roles of microglial membranes in Alzheimer's disease
- PMID: 33837697
- PMCID: PMC8082413
- DOI: 10.1016/bs.ctm.2020.08.007
Roles of microglial membranes in Alzheimer's disease
Abstract
The majority of Alzheimer's disease (AD) risk genes are highly and selectively expressed by microglia in the brain. Several of these genes are related to lipid and cholesterol metabolism, lipid synthesis, lipid transport, endocytosis, exocytosis and phagocytosis. Therefore, studying the roles of cellular membrane biophysics in microglial function should improve our understanding of the AD pathology. In this chapter, we discuss how lipid rafts and membrane-cytoskeleton adhesion impact microglial-mediated oxidative stress and clearance of amyloid-β peptide (Aβ). We also discuss potential roles of lipid membrane-bound extracellular vesicles as carriers of pathological factors to promote inflammation and cytotoxicity.
Keywords: Alzheimer; Amyloid-β peptide; Caveolae; Cholesterol; Exosomes; Inflammation; Lipid rafts; Membrane-cytoskeleton adhesion; Oxidative stress; Tau.
© 2020 Elsevier Inc. All rights reserved.
Figures


Similar articles
-
Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.Elife. 2020 Jun 8;9:e54083. doi: 10.7554/eLife.54083. Elife. 2020. PMID: 32510331 Free PMC article.
-
Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?Curr Alzheimer Res. 2016;13(4):403-12. doi: 10.2174/1567205013666151116125714. Curr Alzheimer Res. 2016. PMID: 26567742 Review.
-
Microglial amyloid beta clearance is driven by PIEZO1 channels.J Neuroinflammation. 2022 Jun 15;19(1):147. doi: 10.1186/s12974-022-02486-y. J Neuroinflammation. 2022. PMID: 35706029 Free PMC article.
-
Lipid Rafts Act as a Common Platform for Amyloid-β Oligomer-Induced Alzheimer's Disease Pathology.J Alzheimers Dis. 2022;87(3):1189-1203. doi: 10.3233/JAD-215662. J Alzheimers Dis. 2022. PMID: 35431249
-
Receptor-ligand interaction controls microglial chemotaxis and amelioration of Alzheimer's disease pathology.J Neurochem. 2023 Sep;166(6):891-903. doi: 10.1111/jnc.15933. Epub 2023 Aug 21. J Neurochem. 2023. PMID: 37603311 Review.
Cited by
-
Caveolae with GLP-1 and NMDA Receptors as Crossfire Points for the Innovative Treatment of Cognitive Dysfunction Associated with Neurodegenerative Diseases.Molecules. 2024 Aug 20;29(16):3922. doi: 10.3390/molecules29163922. Molecules. 2024. PMID: 39203005 Free PMC article. Review.
-
Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research.Mol Neurodegener. 2025 Mar 27;20(1):37. doi: 10.1186/s13024-025-00825-0. Mol Neurodegener. 2025. PMID: 40149001 Free PMC article. Review.
References
-
- Agosta F, Dalla Libera D, Spinelli EG, Finardi A, Canu E, Bergami A, et al. (2014). Myeloid microvesicles in cerebrospinal fluid are associated with myelin damage and neuronal loss in mild cognitive impairment and Alzheimer disease. Annals of Neurology, 76, 813–825. - PubMed
-
- Babior BM (2000). Phagocytes and oxidative stress. The American Journal of Medicine, 109, 33–44. - PubMed
-
- Babior BM (2004). NADPH oxidase. Current Opinion in Immunology, 16, 42–47. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical